Investment
Features
FeesSafety
Academy
More
Pluang+

Pomdoctor to present at H.C. Wainwright conference with virtual access starting Sept 11, 2026

Market News
10 Sep 2026
PRNewsWire
View Source
Neutral
Pomdoctor to present at H.C. Wainwright conference with virtual access starting Sept 11, 2026

Pomdoctor Limited, a digital healthcare company specializing in AI-enabled solutions, will participate in the 28th Annual H.C. Wainwright Global Investment Conference from September 14-16, 2026, in New York City. A pre-recorded presentation will be available online starting September 11, 2026. The company's CEO and COO will hold one-on-one investor meetings during the event. This participation highlights Pomdoctor's efforts to expand its predictive healthcare capabilities and engage with investors on its growth strategy.

More News

Macy's Q1 earnings beat estimates; raises full-year sales forecast on strong brand growth

Macy's Q1 earnings beat estimates; raises full-year sales forecast on strong brand growth

Macy's reported Q1 earnings per share of $0.40, exceeding the $0.37 estimate, with revenue of $4.87 billion beating expectations. Growth was driven by strong sales in Bloomingdale's, Bluemercury, and Macy's stores. The company raised its full-year ne...

Company Fundamentals
Bullish
50 minutes ago
Uber stock downgraded to Neutral amid earnings drop and Tesla competition, despite revenue growth and autonomous vehicle progress.

Uber stock downgraded to Neutral amid earnings drop and Tesla competition, despite revenue growth and autonomous vehicle progress.

Arete Research downgraded Uber's stock from Buy to Neutral with a $74 price target, citing an expected 64.95% drop in earnings per share to $1.09 despite 9.6% revenue growth to $14.76 billion. Uber faces new competition from Tesla's Cybercab, which o...

Analyst Insights
Bearish
3 hours ago
Wealthfront beats Q2 earnings and revenue estimates, showing strong growth in assets and clients.

Wealthfront beats Q2 earnings and revenue estimates, showing strong growth in assets and clients.

Wealthfront Corporation reported better-than-expected Q2 2026 earnings with $0.10 EPS versus $0.08 estimated and revenue of $91.87 million surpassing $91.53 million estimates. The company’s total platform assets grew 12% year-over-year to $99 billion...

Company Fundamentals
Bullish
3 hours ago
Kristin Ess Hair launches on REVOLVE, entering fashion-first retail with 30+ products.

Kristin Ess Hair launches on REVOLVE, entering fashion-first retail with 30+ products.

Kristin Ess Hair, a popular haircare brand under Maesa, has launched its products on REVOLVE, a leading fashion retailer targeting Gen Z and Millennials. The collection includes over 30 items such as the viral Signature Hair Gloss and The One Shampoo...

Others
Bullish
4 hours ago
ADARx Pharmaceuticals files for IPO to fund RNA therapies for serious diseases

ADARx Pharmaceuticals files for IPO to fund RNA therapies for serious diseases

ADARx Pharmaceuticals is pursuing an IPO to raise capital for its RNA-targeted therapy pipeline, focusing on serious liver and non-liver diseases. Its lead drug, Onvuzosiran, is in Phase 3 trials for hereditary angioedema, with key data expected by t...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App